<strong>Central Coast healthcare industry embraces innovations in cancer treatment</strong>
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
SDRI highlights big breakthroughs in 2022
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Central Coast health providers to pay out $68M in settlement
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Additional approval bolsters Amgen cancer treatment
Correction: The headline on this article has been updated. The U.S. Food and Drug Administration has approved Amgen’s supplemental biologics license for Blincyto, which treats adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia, the Thousand Oaks-based life sciences giant announced on June 20. The patients have the leukemia in first or second Read More →
New public biotech firm joins Conejo Valley cluster
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s $28B merger bid gets tougher
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
DOJ, health care orgs reach $68M settlement
The Department of Justice announced June 29 that three major health care providers and a Medi-Cal health plan on the Central Coast will pay $68 million to settle claims they submitted false information related to Medi-Cal and Medicaid reimbursements from 2014 to 2016. The Santa Barbara San Luis Obispo Regional Health Authority, better known as Read More →
